May 16 |
Roche’s New Weight-Loss Data Shows Lilly Isn’t Unbeatable in Obesity
|
May 16 |
Roche (RHHBY) Posts Encouraging Phase I Obesity Drug Data
|
May 16 |
Lilly’s once-weekly insulin matches daily shots in late-stage tests
|
May 16 |
Roche Shares Climb After Weight-Loss Drug Shows Efficacy in Early-Stage Trial
|
May 16 |
Eli Lilly once-weekly insulin hits main goal in late-stage trials
|
May 16 |
These 2 No-Brainer Growth Stocks Are Breaking New Ground
|
May 16 |
UPDATE 2-Lilly's weekly insulin as effective as daily doses in studies
|
May 16 |
With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin
|
May 15 |
Dow Jones Futures: Dow, S&P 500, Nasdaq Hit Highs, Nvidia Leads 12 New Buys; What To Do Now
|
May 15 |
Biogen (BIIB) Partner Begins Filing for Leqembi SC Autoinjector
|